Clindamycin-resistant among Staphylococcus aureus: Investigation into phenotypic and genotypic profiles
PLOS One · 2025
DOI: 10.1371/journal.pone.0329467 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mariyam Khursheed und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Sciences, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Clindamycin, Anti-Bacterial Agents, Staphylococcal Infections, Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar National Research Fund.
Abstract (Originalsprache)
Background
Antimicrobial resistance (AMR), particularly methicillin-resistant Staphylococcus aureus (MRSA), is a pressing global health concern. These bacteria are increasingly becoming resistant to the most commonly available treatment options. As a choice, the macrolide lincosamide-streptogramin B (MLSB) is used, with clindamycin being the preferred drug. However, an alarming number of staphylococcal strains are developing resistance to MLSB. The resistance exhibits several phenotypes, including inducible MLSB (iMLSB), constitutive MLSB (cMLSB), and macrolide streptogramin B (MSB). One of the biggest challenges is the accurate detection of iMLSB in routine laboratory tests, as they appear erythromycin-resistant and clindamycin-sensitive unless the two antibiotics are placed adjacent to each other, which leads to clinical therapeutic failure.
Method
To achieve this, double disc diffusion (D test) was used to test iMLSB phenotypically. In addition, the genetic determinants were identified through singleplex PCR using specific primers to detect erm (A, B, C) and msr genes associated with the different phenotypes of MLSB resistance.
Result
Among 161 S. aureus isolates, 42 (26.1%) were erythromycin-resistant; 25 (15.5%) showed an iMLSB phenotype, and 16 (9.9%) displayed an MSB phenotype. One MRSA isolate expressing cMLSB phenotype. Genotypic analysis revealed a prevalence of erm C in 60% and msr in 40% of S. aureus isolates.
Conclusion
The D-test is a reliable method for identifying inducible clindamycin resistance in clinical diagnostics, to support antibiotic use and treatment stewardship in Qatar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Health Sciences, Qatar University, Doha, Qatar.
- Harvard American School, Doha, Qatar.
- Glangwili Hospital, Wales, United Kingdom.
- Hamad General Hospital, Doha, Qatar.
- Biomedical Research Center, Qatar University, Doha, Qatar.
ORCID-Profile: Godwin Wilson, Nahla O Eltai
Förderung
- Qatar National Research Fund
Zitieren
APA
Khursheed, M., Sulaiman, M., Alhassan, A. M., Al Awad, T. H., Ibrahim, A. E., Wilson, G., Abdelrahaman, H. A., & Eltai, N. O. (2025). Clindamycin-resistant among Staphylococcus aureus: Investigation into phenotypic and genotypic profiles. PLOS One. https://doi.org/10.1371/journal.pone.0329467
Vancouver
Khursheed M, Sulaiman M, Alhassan AM, Al Awad TH, Ibrahim AE, Wilson G, et al. Clindamycin-resistant among Staphylococcus aureus: Investigation into phenotypic and genotypic profiles. PLOS One. 2025. doi:10.1371/journal.pone.0329467
BibTeX
@article{Khursheed2025,
author = {Khursheed, Mariyam and Sulaiman, Maryam and Alhassan, Abdulrahman M and Al Awad, Tameem H and Ibrahim, Ahmed E and Wilson, Godwin and Abdelrahaman, Hana A and Eltai, Nahla O},
title = {Clindamycin-resistant among Staphylococcus aureus: Investigation into phenotypic and genotypic profiles},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0329467}
}
EUVIMED